30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: Artimplant

SEK 4.4MM (~US $0.67MM), -35% (Europe ~$0.16MM, -37%; U.S. ~$0.51MM, -34%)

  • In 2Q, entered into sales/marketing/distribution agreement with Tiller, granting exclusive license to market all Artimplant products ex-Europe, non-exclusive license in Europe